1995
DOI: 10.3109/13506129509036921
|View full text |Cite
|
Sign up to set email alerts
|

Quantification of tissue amyloid content in AA amyloidosis by inhibition ELISA

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

1996
1996
1999
1999

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 12 publications
0
2
0
Order By: Relevance
“…Subsequent characterization of the fibril protein is mandatory to link the deposits with an underlying disease and thus facilitate appropriate medical treatment. The fibril protein can be characterized by biochemical procedures such as high-performance liquid chromatography, electrophoresis, immunoblotting, immunodiffusion, or by immunohistochemistry (Linke 1985;Linke et al 1986;Westermark et al 1986;Yakar et al 1995;Röcken et al 1996;Kaplan et al 1993Kaplan et al ,1997.…”
mentioning
confidence: 99%
“…Subsequent characterization of the fibril protein is mandatory to link the deposits with an underlying disease and thus facilitate appropriate medical treatment. The fibril protein can be characterized by biochemical procedures such as high-performance liquid chromatography, electrophoresis, immunoblotting, immunodiffusion, or by immunohistochemistry (Linke 1985;Linke et al 1986;Westermark et al 1986;Yakar et al 1995;Röcken et al 1996;Kaplan et al 1993Kaplan et al ,1997.…”
mentioning
confidence: 99%
“…An additional advantage will be the characterisation of the amyloid as the amyloid A protein type. Amyloid A protein has already been quantified in small samples (10–60 mg) of mouse and human necropsy tissues of the spleen 10. However, the clinician who treats patients with arthritis needs a procedure that is easy to perform routinely during life, which can be repeated at intervals, and with results that are reproducible and can be obtained within days.…”
mentioning
confidence: 99%